This is a double-blinded, two-arm, randomized, placebo controlled study comparing the
virological efficacy of add-on sirolimus with standard care to placebo and standard care.
Virological efficacy is defined as the change from baseline to day 7 in SARS-CoV-2 viral
burden measured by quantitative real-time polymerase chain reaction.